156 related articles for article (PubMed ID: 32260270)
1. Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles Virus.
Winer H; Ozer J; Shemer Y; Reichenstein I; Eilam-Frenkel B; Benharroch D; Golan-Goldhirsh A; Gopas J
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260270
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from
Weiss S; Waidha K; Rajendran S; Benharroch D; Khalilia J; Levy H; Bar-David E; Golan-Goldhirsh A; Gopas J; Ben-Shmuel A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176034
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of a Nuphar lutea partially purified leaf extract in murine models of septic shock.
Ozer J; Levi T; Golan-Goldhirsh A; Gopas J
J Ethnopharmacol; 2015 Feb; 161():86-91. PubMed ID: 25490314
[TBL] [Abstract][Full Text] [Related]
4. Nuphar lutea: in vitro anti-leishmanial activity against Leishmania major promastigotes and amastigotes.
El-On J; Ozer L; Gopas J; Sneir R; Golan-Goldhirsh A
Phytomedicine; 2009 Aug; 16(8):788-92. PubMed ID: 19303752
[TBL] [Abstract][Full Text] [Related]
5. Nuphar lutea thioalkaloids inhibit the nuclear factor kappaB pathway, potentiate apoptosis and are synergistic with cisplatin and etoposide.
Ozer J; Eisner N; Ostrozhenkova E; Bacher A; Eisenreich W; Benharroch D; Golan-Goldhirsh A; Gopas J
Cancer Biol Ther; 2009 Oct; 8(19):1860-8. PubMed ID: 19713755
[TBL] [Abstract][Full Text] [Related]
6. Leishmania major: anti-leishmanial activity of Nuphar lutea extract mediated by the activation of transcription factor NF-κB.
Ozer L; El-On J; Golan-Goldhirsh A; Gopas J
Exp Parasitol; 2010 Dec; 126(4):510-6. PubMed ID: 20515684
[TBL] [Abstract][Full Text] [Related]
7. 6,6'-Dihydroxythiobinupharidine (DTBN) Purified from
Waidha K; Anto NP; Jayaram DR; Golan-Goldhirsh A; Rajendran S; Livneh E; Gopas J
Molecules; 2021 May; 26(9):. PubMed ID: 34066895
[TBL] [Abstract][Full Text] [Related]
8. Anti-Metastatic Effect of Semi-Purified
Ozer J; Fishman D; Eilam B; Golan-Goldhirsh A; Gopas J
J Cancer; 2017; 8(8):1433-1440. PubMed ID: 28638458
[No Abstract] [Full Text] [Related]
9. Anti-
Shmuel O; Rasti A; Zaknoun M; Astman N; Golan-Goldhirsh A; Sagi O; Gopas J
Pathogens; 2024 May; 13(5):. PubMed ID: 38787236
[TBL] [Abstract][Full Text] [Related]
10. Virucidal Activity of Gold Nanoparticles Synthesized by Green Chemistry Using Garlic Extract.
Meléndez-Villanueva MA; Morán-Santibañez K; Martínez-Sanmiguel JJ; Rangel-López R; Garza-Navarro MA; Rodríguez-Padilla C; Zarate-Triviño DG; Trejo-Ávila LM
Viruses; 2019 Nov; 11(12):. PubMed ID: 31801280
[TBL] [Abstract][Full Text] [Related]
11. Actin-Modulating Protein Cofilin Is Involved in the Formation of Measles Virus Ribonucleoprotein Complex at the Perinuclear Region.
Koga R; Sugita Y; Noda T; Yanagi Y; Ohno S
J Virol; 2015 Oct; 89(20):10524-31. PubMed ID: 26269174
[TBL] [Abstract][Full Text] [Related]
12. The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain.
Duprex WP; Duffy I; McQuaid S; Hamill L; Cosby SL; Billeter MA; Schneider-Schaulies J; ter Meulen V; Rima BK
J Virol; 1999 Aug; 73(8):6916-22. PubMed ID: 10400789
[TBL] [Abstract][Full Text] [Related]
13. Replication of measles virus in Vero cells at elevated temperatures.
Ogura H; Nakamura S
Microbiol Immunol; 1989; 33(11):907-14. PubMed ID: 2593875
[TBL] [Abstract][Full Text] [Related]
14. Design of a small-molecule entry inhibitor with activity against primary measles virus strains.
Plemper RK; Doyle J; Sun A; Prussia A; Cheng LT; Rota PA; Liotta DC; Snyder JP; Compans RW
Antimicrob Agents Chemother; 2005 Sep; 49(9):3755-61. PubMed ID: 16127050
[TBL] [Abstract][Full Text] [Related]
15. [Influence of polyelectrolytes on measles virus infectivity].
Artiushenko SV; Kontarov NA; Iuminova NV; Zverev VV; Kontarova EO; Balaev NV
Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):36-40. PubMed ID: 21913389
[TBL] [Abstract][Full Text] [Related]
16. Measles virus antisense sequences specifically cure cells persistently infected with measles virus.
Koschel K; Brinckmann U; Hoyningen-Huene VV
Virology; 1995 Feb; 207(1):168-78. PubMed ID: 7532884
[TBL] [Abstract][Full Text] [Related]
17. Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases.
Schneider-Schaulies S; Kreth HW; Hofmann G; Billeter M; Ter Meulen V
Virology; 1991 Jun; 182(2):703-11. PubMed ID: 2024495
[TBL] [Abstract][Full Text] [Related]
18. Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity.
White LK; Yoon JJ; Lee JK; Sun A; Du Y; Fu H; Snyder JP; Plemper RK
Antimicrob Agents Chemother; 2007 Jul; 51(7):2293-303. PubMed ID: 17470652
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.
Tiwarekar V; Wohlfahrt J; Fehrholz M; Scholz CJ; Kneitz S; Schneider-Schaulies J
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925665
[TBL] [Abstract][Full Text] [Related]
20. A target site for template-based design of measles virus entry inhibitors.
Plemper RK; Erlandson KJ; Lakdawala AS; Sun A; Prussia A; Boonsombat J; Aki-Sener E; Yalcin I; Yildiz I; Temiz-Arpaci O; Tekiner B; Liotta DC; Snyder JP; Compans RW
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5628-33. PubMed ID: 15056763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
